Pacific Diabetes Technologies

Our hollow glucose sensor reduces the pain and aggravation of diabetes, encouraging better health by managing glucose and insulin with just one needle per week.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Portland, OR, US
  • Currency USD
  • Founded January 2013
  • Employees 9
  • Incorporation Type C-corp
  • Website pacificdt.com

Company Summary

PDT has developed continuous glucose monitoring (CGM) infusion devices to serve patients with insulin-treated diabetes. Our CGM is the only product able to reduce the pain & disruption of diabetes by cutting needle sticks down to one per week. PDT intends to combine contract & in-house manufacturing to produce its devices, with sales via subscription services and OEM channels.

Team

  • Robert Cargill

  • W. Kenneth Ward, MD
    Chairman of the Board, Co-founder

    25 years endocrinology
    20 years sensor development
    Father of OHSU Artificial Pancreas

  • Thomas Seidl, PhD
    Chief Scientific Officer

    Sensor Development & Polymer Synthesis, Bayer/Isense (now Agamatrix)
    Organometallic synthesis
    Process qualification and validation

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free